1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Longitudinal stability of molecular endotypes of knee osteoarthritis patients
(
- Contribution to journal › Article
- 2024
-
Mark
Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death
(
- Contribution to journal › Article
-
Mark
From biochemical markers to molecular endotypes of osteoarthritis : a review on validated biomarkers
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Increased proteolytic cleavage of osteoglycin is associated with a stable plaque phenotype and lower risk of cardiovascular events
(
- Contribution to journal › Article
- 2021
-
Mark
Collagen remodelling and plasma ascorbic acid levels in patients suspected of inherited bleeding disorders harbouring germline variants in collagen‐related genes
(
- Contribution to journal › Article
-
Mark
Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers
(
- Contribution to journal › Scientific review
-
Mark
A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritis
(
- Contribution to journal › Article
- 2019
-
Mark
Protein biomarkers associated with pain mechanisms in osteoarthritis
(
- Contribution to journal › Article
-
Mark
Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model
(
- Contribution to journal › Article
-
Mark
GPDPLQ1237—A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro
(
- Contribution to journal › Article